Form 4: Inogen CEO Smith Boosts Stake with RSU Vesting, ESPP

Inogen Inc. CEO and President Kevin Raymond Smith reported significant equity transactions, including RSU vesting, tax-related dispositions, and an Employee Stock Purchase Plan acquisition.

Summary

• Kevin Raymond Smith, CEO and President of Inogen Inc., reported multiple equity transactions on February 27, 2026, and March 1, 2026.
• Acquired 685 shares of common stock through the Company's 2014 Employee Stock Purchase Plan at a price of $6.1 per share.
• Earned and vested 32,725 shares of common stock from a 2023 performance-based restricted stock unit award, based on 2025 fiscal year financial performance.
• Vested 28,334 shares of common stock from a time-based restricted stock unit award, with 1/3rd vesting on March 1, 2025, and annually thereafter.
• Vested 30,012 shares of common stock from another time-based restricted stock unit award, with 1/3rd vesting on March 1, 2026, and annually thereafter.
• Disposed of a total of 44,585 shares of common stock at $6.1 per share to cover tax withholding liabilities related to the vesting of both performance-based and time-based restricted stock unit awards.
• Received a new grant of 90,000 Restricted Stock Units (RSUs) on February 27, 2026, which will vest in three equal annual installments starting March 1, 2027.
• Following these transactions, Smith directly beneficially owns 133,462 shares of Inogen common stock and 90,000 unvested Restricted Stock Units.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing. While there are dispositions for tax purposes, the overall increase in beneficial ownership through RSU vesting and ESPP purchase, coupled with a new RSU grant, indicates continued alignment of management's interests with shareholders and achievement of performance targets.

Positives

• CEO Kevin Raymond Smith increased his direct beneficial ownership of common stock through vesting of performance-based and time-based restricted stock units, demonstrating continued equity stake in the company.
• Participation in the Employee Stock Purchase Plan (ESPP) by acquiring 685 shares at $6.1 indicates a personal investment at market price.
• The vesting of performance-based RSUs signifies the achievement of financial performance conditions for the 2025 fiscal year, which is a positive indicator for the company's operational success.
• A new grant of 90,000 Restricted Stock Units aligns management incentives with long-term shareholder value.

Negatives

• A significant number of shares (44,585) were disposed of to cover tax withholding liabilities, which represents a reduction in the immediate share count held by the CEO, though it is a standard practice for RSU vesting.

Future Outlook

The newly granted 90,000 Restricted Stock Units are subject to future vesting schedules, with the first tranche vesting on March 1, 2027, and subsequent tranches annually thereafter, contingent on continued service.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those involving equity compensation and routine tax withholdings, are common in publicly traded companies. The vesting of performance-based awards suggests that Inogen Inc. met certain financial targets for the 2025 fiscal year, which can be a positive signal for the company's operational health within the medical technology industry.

Stakeholder Impact

• Shareholders: Increased insider ownership (net of tax withholding) can signal management's confidence in the company's future, potentially aligning interests. The achievement of performance conditions for RSU vesting is a positive for company performance.
• Employees: The Employee Stock Purchase Plan (ESPP) is a benefit for employees, and RSU grants are a common form of executive compensation.

Next Steps

• Further vesting of the 90,000 Restricted Stock Units on March 1, 2027, and annually thereafter.
• Future vesting of remaining tranches from previously granted time-based restricted stock unit awards.

Key Dates

Keywords

Inogen Inc, INGN, Kevin Raymond Smith, CEO, Insider Trading, Form 4, Restricted Stock Units, RSU Vesting, Employee Stock Purchase Plan, ESPP, Equity Compensation, Stock Ownership